Related Experiment Video
Updated: Jul 31, 2025
09:02
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.0K
Palliative Care in Patients with Hematological Malignancies
Seckin Erdal1, Elif Naz Arslan2, Mehmet Sahir Tandoruk3
1Adult Bone Marrow Transplantation Unit, Acıbadem Altunizade Hospital, Nurse in Charge, İstanbul, Turkey.
Florence Nightingale Journal of Nursing
|May 10, 2023
Summary
Palliative care improves quality of life for patients with incurable diseases. This study examines palliative care needs and barriers in hematologic malignancies to enhance patient well-being.
Area of Science:
- Oncology
- Palliative Medicine
- Hematology
Background:
- Palliative care enhances quality of life by addressing physical, mental, and psychosocial issues in patients with incurable conditions.
- While recommended for solid tumors, palliative care is underutilized in hematologic malignancies.
- Patients with hematologic malignancies experience significant physical, mental, and economic challenges due to intensive treatments and side effects.
Purpose of the Study:
- To define the palliative care needs of patients with hematologic malignancies.
- To understand barriers to palliative and end-of-life care for this patient group.
- To propose solutions for improving quality of life and care for patients with hematologic malignancies.
Main Methods:
- Literature review and synthesis of existing research on palliative care in hematologic malignancies.
- Analysis of patient-reported outcomes and healthcare utilization data.
- Qualitative assessment of barriers through expert interviews and case studies.
Main Results:
- Hematologic malignancy patients face unique symptom burdens and treatment complexities impacting quality of life.
- Significant gaps exist in the integration and recommendation of palliative care for these patients.
- Barriers include lack of awareness, limited access, and insufficient training among healthcare providers.
Conclusions:
- Palliative care is crucial for improving the quality of life and care for patients with hematologic malignancies.
- Addressing identified barriers is essential for equitable access to palliative and end-of-life care.
- Further research and implementation strategies are needed to optimize palliative care delivery in hematology.
Related Concept Videos
01:25Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:22Bone Marrow Sampling and Transplants
365
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
365
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Nursing Ethical Principles II
1.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K